HNRNPA1L2 Antilichaam - N-terminalgebied: FITC (ARP40282 T100-FITC)

Heterogeneous nuclear ribonucleoprotein A1-like 2

144983

Q32P51

NP_001011724

Human, Mouse, Rat, Cow, Dog, Guinea Pig, Horse, Rabbit

The immunogen is a synthetic peptide directed towards the N terminal region of human HNRNPA1L2.

The function remains unknown.

UBC; HCVgp1; ESR1; HNRNPA3; BZW1; RAB1A; SERPINH1; Recql4; Cep55; Cdk1; Cbx1

FITC: Fluorescein Isothiocyanate

Polyclonal Antibody

IHC, WB

HNRNPA1L2 is strongly supported by BioGPS gene expression data to be expressed in Jurkat

0.5 mg/ml

Cow: 93%; Dog: 100%; Guinea Pig: 93%; Horse: 93%; Human: 100%; Mouse: 100%; Rabbit: 100%; Rat: 100%

Liquid. Purified antibody supplied in 1x PBS buffer.

All conjugated antibodies should be stored in light-protected vials or covered with a light protecting material (i.e. aluminum foil) . Conjugated antibodies are stable for at least 12 months at 4C. If longer storage is desired (24 months), conjugates may be diluted with up to 50% glycerol and stored at -20C to -80C. Freezing and thawing conjugated antibodies will compromise enzyme activity as well as antibody binding.

35kDa

Ota, T., (2004) Nat. Genet. 36 (1), 40-45

Wet Ice

320

HNRNPA1L2

HNRNPA1L2

Rabbit

Heterogeneous nuclear ribonucleoprotein A1-like 2

NM_001011724

MSKSASPKEPEQLRKLFIGGLSFETTDESLRSHFEQWGTLTDCVVMRDPN